FindTrial
Sign In

Efficacy of argon laser peripheral iridoplasty on medically unresponsive Chinese patients with acute angle closure glaucoma

Efficacy of argon laser peripheral iridoplasty on medically unresponsive Chinese patients with acute angle closure glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNC-10001168
Enrollment
Unknown
Registered
2010-12-27
Start date
2007-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Angle Closure Glaucoma

Interventions

1:argon laser peripheral iridoplasty

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagonosed acute angle closure glaucoma patients; 2. Unresponsive to intensive medical treatment for more than 2 days

Exclusion criteria

Exclusion criteria: 1. Do not sign the consent form; 2. Younger than 18 years old; 3. With other severe general diseases

Design outcomes

Primary

MeasureTime frame
intraocular pressure;—

Countries

China

Contacts

Public ContactGuoping QING, M.D.
wninglibj@126.com+86 10 58268236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026